CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at an average $4.69 ($23,426)
- 4 Open-market buy Director bought 6,000 shares at $4.67 ($28,020)
- 4 Open-market buy Director bought 5,000 shares at an average $4.39 ($21,935)
- 4 Open-market buy Chief Scientific Officer bought 2,000 shares at an average $7.46 ($14,912)
- 4/A Open-market buy President and CEO bought 2,000 shares at $7.31 ($14,620)
- 4 Grant or award President and CEO acquired 2,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 14 of 17 · 325 filings